»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ |4mpohX
IKMeJ(:
S
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨»ù´¡¿Î£©¿ÆÄ¿´úÂ룺806 IW8+_#d
x\&`>>uA
Ò»Ãû´Ê½âÊÍ£¨¹²5Ì⣬ÿÌâ4·Ö£¬¹²20·Ö£© IM$2VlC
1.Antigen presenting cell£¨APC£© 6C>_a*w
2.Activation induced cell death£¨AICD£© [S.ZJUns
3.Chemokine {7cX#1
4.Major histocompatibility complex£¨MHC£© -y
GDh+-
5.immunotolerance e{;OSk`x
T5Q{{ @Q
¶þÎÊ´ðÌ⣨¹²5Ì⣬ÿÌâ10·Ö£¬¹²50·Ö£© 6:U$w7P0
e
1.ÊÔÊö²ÎÓëThϸ°ûÓëBϸ°ûÏ໥¼¤»îµÄ·Ö×Ó¼°¸÷×ԵŦÄÜ {X2`&<i6
2.ºÎν𤸽·Ö×Ó£¿¼òÊö𤸽·Ö×ӵķÖÀ༰ÆäÔÚÃâÒßÖеÄ×÷Óà t NsPB6Z
3.¼òÊöIIÐͳ¬Ãô·´Ó¦µÄ·¢Éú»úÖÆ Lb{e,JH
4.ÔÚÕý³£Çé¿öÏ£¬ÃâÒßϵͳ¶Ô×ÔÉí¿¹Ô²»²úÉúÃâÒßÓ¦´ðµÄ»úÖÆÊÇʲô£¿ ]
2DH;
5.±È½ÏCTLºÍNKɱÉË°Ðϸ°ûʱʶ±ðºÍɱÉË»úÖƵÄÌصã =.y*
_Ja
-p-B2?)A
ÈýÑ¡´ðÌ⣨µÚ1Ìâ±Ø´ð£¬2ºÍ3ÌâÈÎÑ¡1Ì⣬ÿÌâ15·Ö£¬¹²30·Ö£© Qr1e@ =B
1.¼òÊöÒÆÖ²ÅųⷴӦÖÐÊÜÕßTϸ°û¶ÔͬÖÖÒìÌ忹ԵÄʶ±ð»úÖÆ¡£Í¨¹ýÖ±½Óʶ±ð¼¤»îµÄÊÜÕßThϸ°ûºÍTcϸ°û·Ö±ðÔÚ¸¨ÖúÊÜÕßBϸ°ûºÍɱÉËÒÆÖ²Îï·½ÃæÓë¼ä½Óʶ±ð¼¤»îµÄThºÍTcÓкβîÒ죿Ϊʲô£¿ 2&+#Vsm`V
2.½áºÏÄãµÄרҵÊÔÊöϸ°ûÒò×ÓÔÚ¼²²¡·¢Éú·¢Õ¹ÖеÄ×÷Óã¬Ä㽫²ÉÈ¡ÄÄЩ²ßÂÔÕë¶ÔÕâЩ°ÐµãÖÎÁƼ²²¡£¿ )uv=S;+
3.ºÎΪ»ùÒò¹¤³Ì¿¹Ì壿Ŀǰ¹úÄÚÍâÔÚ»ùÒò¹¤³Ì¿¹ÌåÑо¿ÖÐÓÐÄÄЩÖ÷Òª½øÕ¹£¿ QDpEb=|S
n~g)I&
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ2003Äê¹¥¶Á²©Ê¿Ñ§Î»Ñо¿ÉúÈëѧ¿¼ÊÔÊÔÌâ yNm:[bOER
Xh J,"=E+
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ£¨×¨Òµ¿Î£©¿ÆÄ¿´úÂ룺906 IHgeQ F
~
t}v2$<!I
Ò»Ãû´Ê½âÊÍ£¨4·Ö/Ì⣩ 0y<wvLv2C
1.Antigenic determinant =%zLh<3v
2.IgSF K1V#cB
WO
3.MBL;¾¶ s>0Nr
4.chemokine
)1g"?]
5.HLA¸´ºÏÌåµÄ¶à»ùÒòÐÔÓë¶àëÄÐÔ LqdY Qd51
6.TCR-CD3¸´ºÏÎï Qb8
KPpd
7.FADD£¨Fas-associated protein with death domain£© =AVgIv
8.AIDS _"4xKh)
9.Tumor rejection antigen q1E:l!2al
10.AICD "EU{8b
A:<;M@q!
¶þÎÊ´ðÌ⣨15·Ö/Ì⣩ R),zl_d_
1.¼òÊöCD·Ö×ÓÔÚÃâÒßЧӦÖеÄ×÷Ó㨰´ÊÜÌå·ÖÀà¼òÊö£© 47r_y\U h
2.¼òÊöBϸ°û²ÎÓëµÄÃâÒß¹¦ÄÜ z} '! eCl
3.¼òÊö×ÔÉíÃâÒßÐÔ¼²²¡Ê±Õë¶Ô×ÔÉí×éÖ¯²úÉúÃâÒßÓ¦´ðµÄ¿ÉÄÜ»úÖÆ i(?,6)9
4.ºÎνͬÖÖÒìÐÍMHC¿¹ÔÖ±½Óʶ±ðºÍ¼ä½Óʶ±ð£¿¼òÊöÆäÒì Jc)^49Rf
X7L8h'(@
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¶þÄê¹¥¶Á˶ʿÑо¿ÉúÈëѧÊÔÌâ vK$"# F~
9 2MTX
Osp
eMRar<)+#*
רҵ¿Î ÃâÒßѧ S4witIK5
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê +i\&6HGK;-
1. Immunotoxin 2. T inducer 3. T cell receptor 4. Accessory cell yfU<UQ!1
5. Fc¦Å receptor 6. Cytokine /~4"No@
¶þ¡¢ ÎÊ´ðÌâ &D%(~|'
1. ÃâÒßϵͳÖУ¬ÄÄЩϸ°ûÄÜÌØÒì»ò·ÇÌØÒâÐÔµØɱÉË°Ðϸ°û£¬ÊÔ·Ö±ð¼òÊöɱÉË×÷ÓõIJ»Í¬Ìص㡣 (;. AS
2. ¸ù¾ÝT¡¢Bϸ°û±íÃæ±êÖ¾µÄ²»Í¬£¬¿ÉÒÔÓ¦ÓÃÄÄЩÃâÒßѧ¼¼Êõ¼ø±ðÕâÁ½Ààϸ°û£¬¼òÊöÓйصÄʵÑéÔÀí£¿ Wlh~)
3. ÔÚIVÐͳ¬Ãô·´Ó¦ÖУ¬ÖÂÃôTϸ°ûÊÍ·ÅÄÄЩÁÜ°ÍÒò×Ó²ÎÓëÃâÒßËðÉË£¬ÏêÊöÆä×÷ÓûúÀí¡£ *&AfR8x_z
4. ÊÔÊöHLA¸´ºÏÌåµÄÒÅ´«Ìص㼰ÕâЩÌصãµÄÉúÎïѧÒâÒ壿 #k3t3az2{
5. ºÎνµ¥¿Ë¡¿¹Ì壿ÏêÊöÆäÔÚ»ù´¡ÓëÁÙ´²Ò½Ñ§ÖеÄÓ¦Óᣠv){ .Z^_C
nN$Y(2ZN
C0=9K@FCb
F_xbwa*=
7?OH,^
{b]aC
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÈýÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ }AZc8o-
7^}Ll@
1B*Wf
P~
רҵ¿Î ÃâÒßѧ k7tYa;C
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê n6F/Ac:
1¡¢ Complement receptor type ¢ñ 2¡¢ Serologically defined antigen ,(a5 @H$f
3¡¢ Transfer factor 4¡¢ Immunotoxin 5¡¢ Perforin = sAn,ri
6¡¢ Arthus reaction 7¡¢ Network theoty 8.Lymphocyte transformation test s=?aox7
9. Hybridoma technic 10.Mitogen W"L&fV+3
11.Dentritic cell 12.Immunoproliferation 0oy-os
¶þ¡¢ »Ø´ðÏÂÁÐÎÊÌâ k
{-
1¡¢ ÍÌÊÉϸ°û¶Ôϸ¾úµÄÍÌÊɹý³Ì°üÀ¨Äļ¸¸öÖ÷Òª½×¶Î£¬ÊÔÏêÊöÖ®¡£ =O|c-k,f@
2¡¢ ÊÔÊöIL-2µÄϸ°ûÀ´Ô´¹¦Äܼ°ÁÙ´²Ó¦ÓᣠR`F,aIJ]
3¡¢ Ò©Îï»ò»¯Ñ§ÊÔ¼ÁÒýÆðµÄÒ©ÕîÊôÓÚʲôÐͳ¬Ãô·´Ó¦£¬ÊÔÊöÆä»úÀí¡£ UDf9FnG}L
4¡¢ ÌåÄÚµÄÃâÒß·Ö×Ó°üÀ¨Äļ¸ÀࣿÊÔ¼òÊö¸÷ÀàÃâÒß·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡£ # N~,F@t
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¿ÊÔ·Ö±ð¼òÊöËüÃǵÄÖ÷ÒªÔÀí¡£ -{h
^4%Zvl
bIt=v)%$
DjMf,wX-{
s!/TU
{8J
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅËÄÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ - ~O'vLG
_eLWQ|6Fx
C@o%J.9"#
רҵ¿Î ÃâÒßѧ A`O <6
Ò»¡¢ Ãû´Ê½âÊÍ `Lyq[zg8
1¡¢ ³Ù·¢Ðͱä̬·´Ó¦Tϸ°û 2¡¢ C1ÒÖÖÆÎï cIXwiC8t
3¡¢ ¼¯Âä´Ì¼¤Òò×Ó 4¡¢ ¿¹ÔÌá³Ê×÷Óà e2CV6F@a
5¡¢ HIAÓë¼²²¡µÄ¹ØÁª 6¡¢ Ë«¹¦ÄÜ¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ N132sN2
¶þ¡¢ ÎÊ´ðÌâ 8:ggECD
1¡¢ TÁÜ°Íϸ°û¾ßÓÐÄÄЩ±íÃæ±êÖ¾£¿ÊÔÊö¸÷±íÃæ±êÖ¾µÄÉúÎïѧ×÷Óü°/»òÒâÒå¡£ QzGV.Mt2
2¡¢ ÊÔÊöÒÆÖ²ÅųⷴӦµÄÃâÒßÓ¦´ð¹ý³Ì¼°²ÎÓëÅųⷴӦµÄÖÂÃôÁÜ°Íϸ°ûºÍЧӦÎïÖÊ¡£ vUQFQ
3¡¢ ºÎνϸ°ûÒò×Ó£¿¼òÊöÆ乲ͬÌص㼰ÓëÁÙ´²µÄ¹Øϵ¡£ Al)$An-
4¡¢ ºÎνÁÜ°Íϸ°ûÔÓ½»Áö¼¼Êõ£¬ÊÔÊöÆäÔÀí¼°ÒâÒå¡£ dAx96Og:X"
5¡¢ ºÎνÉúÎïËØ-Ç׺ÍËØϵͳ£¿ÊÔÊöÆäÓ¦ÓÃÓÚÃâÒß±ê¼Ç¼¼ÊõµÄÔÀí£¬ÒÔABC·¨ÎªÀý˵Ã÷Ö®¡£ Z+s%;f;
5,+\`!g
h
-_&MD/J
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÎåÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ <*'cf2Q$Av
l52a\/
kD~uGA
רҵ¿Î ÃâÒßѧ `ZHP1uQ<
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê WbjF]b\
1¡¢ SmIg 2¡¢ Graft-versus-host reaction GVHR
TmEYW<
3¡¢ Immunocompent cell ICC 4¡¢ Tumor-associated antigen TAA J$uM 03
5¡¢ Cytokine 6¡¢ Immune tolerance 7¡¢ Biological responsw modifier BRM 5$l9@0D.\
¶þ¡¢ ÎÊ´ðÌâ T)u4S[
&
1¡¢ ÃâÒßϵͳÄÚÆðɱÉËЧӦµÄϸ°ûÓÐÄÄЩ£¿ÊÔ¼òÊöÆäɱÉËЧӦµÄÌص㡣 ka7uK][
2¡¢ ºÎν¿¹ÌåµÄ¶àÑùÐÔ£¿¿¹ÌåµÄ¶àÑùÐÔ±íÏÖÔÚÄÄЩ·½Ã棿¼òÊö²úÉú¿¹Ìå¶àÑùÐÔµÄÔÀí¡£ +Al>2 ~
3¡¢ ÊÔÊö¢òÐÍÓë¢óÐͳ¬Ãô·´Ó¦·¢Éú»úÖƵÄÒìͬµã¡£ $&-5;4R'0
4¡¢ ºÎνMHC£¿ÊÔ¼òÊöÆ书ÄÜ¡£ $B\E.ml.
5¡¢ ºÎνÃâÒß±ê¼Ç¼¼Êõ£¿Ö÷ÒªÓÐÄļ¸ÀàÃâÒß±ê¼Ç¼¼Êõ£¬ÒÔø±ê¼Ç¼¼ÊõΪÀý¼òÊöÆäÖ÷ÒªÔÀí¡£ ryD%i"g<
-R+zeu(e'
\4~AI=aw,T
+Takde%~
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÁùÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ cFfTYP9
2PC5^Ni/9@
4be>
`d5j
רҵ¿Î ÃâÒßѧ 4_Rdp`x#J
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê mVf.sA8
1. IgSF 2. Fc 3. Flow cytometry 4. Adhesion molecule aPIr_7e
5. Autogous mixed lymphoyte reaction #qL9{P<}
¶þ¡¢ ÎÊ´ðÌâ ]S/G\z
1. ÊÔÊöÍâÀ´TD¿¹Ô½øÈë»úÌåÓÕµ¼¿¹Ìå²úÉúµÄÈ«¹ý³Ì¡£ a+(j?_FyI
2. ºÎνϸ°ûÒò×Ó£¿¼òÊöIL-2µÄ¼ì²â·½·¨¼°ÆäÔÀí¡£ )LFD6\z1pl
3. ¼òÊö¿¹¶ÀÌØÐÍÍøÂçµÄµ÷¿Ø×÷Óᣠ;<6"JP>0
4. ÃâÒßÓ¦´ð¶Ô»úÌåÓкÎÀûº¦¹Øϵ£¿ P.4E{.)(
8=H\?4)()Y
v&0d$@6/U
Z] { @H
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾ÅÆßÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ _
VKgs]Y
z-Hkz
*F
Pg#a+
רҵ¿Î ÃâÒßѧ "Pdvmur
zzJ^x8#R
$%}>zqD1
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê Fzs>J&sY&
1. Idiotupe 2. Opsonization 3. Epitope 4. Immunologic tolerance [t}):}~F|
5. Delayed type hypersensitivity *PcVSEP/0
¶þ¡¢ ÎÊ´ðÌâ gHH&IzHF
1. ÊÔÊö²¹Ì徵伤»î;¾¶ÓëÅÔ·¼¤»î;¾¶µÄÒìͬ¡£ HD|sr{Z%
2. ¼òÊö¿¹ÌåµÄ»ù±¾½á¹¹£¨ÒÔIgGΪÀý£©Ó빦ÄÜ¡£ pGk"3.ce
3. ¼òÊöHLAÓëҽѧµÄ¹Øϵ¡£ cju@W]
!
4. ÊÔÊöµ¥ºË/¾ÞÊÉϸ°ûÔÚÃâÒßÓ¦´ðÖеÄ×÷Óᣠ9S"N4c>
5. ¼òÊöÃâÒßÓ¦´ðÖи÷ÖÖÀàÐ͵Äϸ°û¶¾×÷Óá£
oP-;y&AS
"gg(tp45
:|($,3*
XPVV+.
:~r#LRgc
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å°ËÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ %JaE4&
|0DP}
`~
8!6<p[_
רҵ¿Î ÃâÒßѧ bXm:]?
Ò»¡¢ ·Òë²¢½âÊÍÏÂÁÐÃû´Ê 0$?qoS
1. hypersensitivity 2. cluster of differentiation Si[eAAd'
:
3. adhesion molecules 4. supper antigen 5. split tolerance *vXD
uhQ
¶þ¡¢ ÎÊ´ðÌâ <tU
:U<ea]
1. ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ÓµÄÖ÷ÒªÉúÎïѧ»îÐÔ¡£ :%>oe> _"
2. ¼òÊöMHC¿¹ÔµÄ·Ö×ӽṹ¼°Æä×éÖ¯·Ö²¼¡£ =%)})
3. ÊÔÊöÐØÏÙÒÀÀµÐÔ¿¹ÔÒýÆðÌåÒºÃâÒßÓ¦´ðµÄÈ«¹ý³Ì£¨°üÀ¨³õ´ÎÃâÒßÓ¦´ðºÍÔÙ´ÎÃâÒßÓ¦´ð£©¡£ kFnUJM$r
4. Ϊʲô˵²¹Ì弤»î;¾¶Ö÷Òª²ÎÓëÌìÈ»ÃâÒߣ¿ÊÔÊö²¹ÌåÊÇÈçºÎ¾¹ýÅÔ·;¾¶¶ø±»¼¤»îµÄ¡£ -YAO3
5. Ϊʲô¿¹Ä³Ò»Ï¸°ûÒò×ÓÊÜÌåµÄµ¥¿Ë¡¿¹ÔÌ壬ÓбíÏÖ³öÊÜÌå·â±Õ×÷Ó㬶øÓеÄÔò±íÏÖ³öÊÜÌå´Ì¼¤×÷Óã¿ (A|B@a!Y>
:(RL8
;]"n?uo
iPNd!_
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ q>c+bo
6
רҵ¿Î ÃâÒßѧ >Ziy1Dp
Ò»¡¢ Ãû´Ê½âÊÍ DZF[dxH
1. ¿¹ÔÐÔ 2. ÃâÒßÇòµ°°×³¬¼Ò×å 3. ¶ÀÌØÐÍ 4. ¿¹Ô¾ö¶¨×å pO5v*oONz+
5. GVHR CARq^xI-
¶þ¡¢ ÎÊ´ðÌâ '%3u%;"
1. Á½ÖÖ²¹Ì弤»î;¾¶µÄµ÷½ÚÒò×ÓÓÐÄÄЩ£¿±È½ÏËüÃÇÁ½ÖÖ;¾¶ÖеÄ×÷Óᣠ37,L**Dgs
2. ¢òÐͳ¬Ãô·´Ó¦µÄ»úÀíÌصãÊÇʲô£¿¾Ù³öÈý¸ö¢òÐͳ¬Ãô·´Ó¦µÄÀý×Ó¡£ +i2YX7Of
3. ÊÔÊöϸ°ûÒò×ÓµÄ×÷ÓÃÌص㡣 -.^= Z!=M
4. Bcell½éµ¼µÄÌåÒºÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ u;QH8LK
5. MPSµÄÃâÒßѧ¹¦ÄÜ¡£ $)4GCP
54;l*}8Hl
.$n$%|"H-
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ Qs~d_;
;,()wH
b*@&c9I;q
רҵ¿Î ÃâÒßѧ .Gjr`6R
Ò»¡¢Ãû´Ê½âÊÍ |C&%S"*
+D
1. ÃâÒßÇòµ°°×µÄ¶ÀÌØÐÍ 2. 𤸽·Ö×Ó 3. ÃâÒßÇòµ°°×³¬¼Ò×å rDK;6H:u{
4. ¸ÉÈÅËØ 5. HLAµÄ¶à̬ÐÔ 6. ÐØÏÙÒÀÀµÐÔ¿¹Ô 7. ÃâÒßÄÍÊÜ +"TI_tK,S
8. ËÙ·¢Ðͳ¬Ãô·´Ó¦ 9. µ¥¿Ë¡¿¹Ìå 10. ²¹Ì徵伤»î;¾¶ F]/L!
11. »ìºÏÁÜ°Íϸ°û·´Ó¦ 12. ÓÐË¿·ÖÁÑ m+;B!46
Èý¡¢ ÎÊ´ðÌâ A%.J%[MVz
1. ÊÔ¼òÊö¾ÞÊÉϸ°ûÌá³ÊTD¿¹ÔµÄ¹ý³Ì¡£ pj
aiAe!k
2. ÊÔ¼òÊöÒÆÖ²ÎËÞÖ÷·´Ó¦µÄ·¢Éú»úÖÆ HTR "mQ
3. ÊÔÊö²¹ÌåµÄÖ÷ÒªÉúÎïѧ×÷Óà s
ZlJ/_g
4. ÒÔIgGΪÀý£¬ÊÔÊöÃâÒßÇòµ°°×·Ö×ӵĻù±¾½á¹¹ u^j8
XOT
5. ÊÔÊöTϸ°ûµÄÖ÷Òª±íÃæ±êÖ¾¼°¹¦ÄÜ H={O13
x*5 Ch~<k
]}UeuF\
vLi/ '|7
ͬ¼ÃÒ½¿Æ´óѧһ¾Å¾Å¾ÅÄê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ [q0_7
lBizC5t!o
^KaqvG$ed
רҵ¿Î ÃâÒßѧ GoGohsj
Ò»¡¢Ãû´Ê½âÊÍ R=#q"9qz
1. Ig¶ÀÌØÐÍ 2. SAg 3. 𤸽·Ö×Ó 4. CSF 5. IgSF 6. Tϸ°û»î»¯µÄ´Ì¼¤·Ö×Ó =!1-AR%.^
7. HLAÓë¼²²¡µÄ¹ØÁª 8. ELISA 9. ÁÜ°Íϸ°ûµÄ±íÃæ±êÖ¾ ]%cHm4#m3
Èý¡¢ ÎÊ´ðÌâ %J/fg<W1
1. ¼òÊöTÁÜ°Íϸ°ûµÄ·ÖÀ༰¹¦ÄÜ£¿ /8P4%[\
2. ¼òÊöHLAÍ»±äÌåµÄ»ùÒò×é³É¼°HLAµÄ¹¦ÄÜ£¿ T:w2
3. ¼òÊö»úÌå¶ÔÍâÔ´ÐÔ¿¹Ô£¨ÒìÎԣ©µÄ´¦Àí£¬ÈçIgÌá³Ê¹ý³Ì£¿ D[>XwL
4. ¼òÊö²¹ÌåÁ½ÖÖ¼¤»î;¾¶µÄ»ù±¾¹ý³Ì£¬²¢±È½Ï¶þÕßÒìͬ£¿ m<X#W W)N
5. ¼òÊöAIDSÖÐCD4+ϸ°û¼õÉٵĻúÖÆ£¿ oP43 NN~
CYTuj>Ww
Y:tW]
!%Z)eO~Z
V8KTNt%
99Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ +7U
A%q
Ò»¡¢Ãû´Ê½âÊÍ kB$,1J$q
2¡¢ HLAµÄ¶à̬ÐÔ 3¡¢ 𤸽·Ö×Ó 4¡¢ ¶ÀÌØÐÍ 5¡¢ ¿¹ÔëÄתÔËÎï 1{\,5U&
6¡¢ Ig³¬¼Ò×å 7¡¢ µòÍö 8¡¢ ÓÐË¿·ÖÁÑÔ 9¡¢ CD4·Ö×Ó #G[
*2h~99
10¡¢ ³¬Ãô·´Ó¦ 11¡¢ ×ÔÉíÃâÒß²¡ .Y^d9
.
¶þ¡¢ ÎÊ´ðÌâ LoV*YSDAY
1¡¢ ÊÔÊöÍâÔ´ÐÔ¿¹ÔºÍÄÚÔ´ÐÔ¿¹ÔÌá³ÊµÄ¹ý³Ì¡£ e@2E0u4
2¡¢ ÊÔÊöBϸ°û½éµ¼µÄÔÙ´ÎÃâÒßÓ¦´ðµÄ¹ý³Ì¡£ c|R3,<Q]
3¡¢ ÊÔÊö·Ö×ÓˮƽµÄÃâÒßµ÷½Ú¡£ BW;=i.
4¡¢ ÊÔÊö»ñµÃÐÔÃâÒßȱÏÝ×ÛºÏÕ÷£¨AIDS£©µÄ·¢²¡»úÖÆ¡£ \U<F\
i
W=;(t
2000Äê˶ʿÑо¿ÉúÃâÒßѧÊÔÌâ NejsI un%
Ò»¡¢ Ãû´Ê½âÊÍ oC@"^>4
1¡¢ µ÷Àí×÷Óà 2¡¢ 𤸽·Ö×Ó 3¡¢ ³¬¿¹Ô 4¡¢ ÃâÒßȱÏݲ¡ D@lAT#vA
5¡¢ FasÓëFasL 6¡¢ µ¥¿Ë¡¿¹Ìå 7¡¢ ÃâÒßÄÍÊÜ FgHB1x4;
8¡¢ ÒÆÖ²ÎËÞÖ÷·´Ó¦£*****VHR£© 9¡¢ Ö×ÁöÏà¹Ø¿¹Ô£¨TAA£© +*:x#$phx
10¡¢ ÒõÐÔÑ¡Ôñ RB$ 8^#
¶þ¡¢ ÎÊ´ðÌâ &ls!IN
1¡¢ ºÎνϸ°ûÒò×Ó£¿ÊÔÊöϸ°ûÒò×ӵĹ²Í¬Ìص㣿 Z|cTzunp
2¡¢ ºÎνAPC¼°ÆäÖÖÀࣿ¼òÊöÍâÔ´ÐÔ¿¹ÔµÄÈÜøÌåÌá³Ê;¾¶£¿ x#}j3"
PP
3¡¢ ¼òÊöϸ°ûÃâÒßÓ¦´ðµÄÁ½ÀàЧӦϸ°ûµÄЧӦ»úÖÆ£¿Ï¸°ûÃâÒßµÄÉúÎïѧÒâÒ壿 qu#@F\gX
4¡¢ ºÎνMHC£¿¼òÊöMHCµÄ¹¦ÄÜ£¿ ,<
)/45
5¡¢ ºÎν×ÔÉíÃâÒß²¡£¿¼òÊö×ÔÉíÃâÒß²¡µÄ×éÖ¯ËðÉË»úÖÆ£¿. 8G[Y9A(bmP
,mE]?XyO
0t:|l@zB
&:cTo(C'
ͬ¼ÃÒ½¿Æ´óѧ2000Äê¹¥¶Á˶ʿѧλÑо¿ÉúÈëѧÊÔÌâ /O(;~1B
JG+g88
)8
N)Z~h
רҵ¿Î ÃâÒßѧ |"tV["a
Ò»¡¢½«ÏÂÁÐÓ¢Óïµ¥´Ê·Òë³ÉÖÐÎIJ¢Ãû´Ê½âÊÍ Bc9|rl V,
1. Cytokines 2. adhesion molecules 3. graft versus host reaction WE Svkm;
4. immunologic tolerance 5. Opsonization -)->Jx:{
Èý¡¢ ÎÊ´ðÌâ L+0N@`nRF
1. ʲôÊÇMHC£¿ÊÔÊöMHC-¢òÀà·Ö×ӵĽṹ¡¢¸÷²¿Î»¹¦ÄÜ£¬MHC-¢òÀà·Ö×ÓµÄ×éÖ¯·Ö²¼¼°ÆäÃâÒßѧ×÷Óᣠ>*Qk~kv<%
2. ÓÐÄÄÈý´ú¿¹Ì壿ÊÔÊö¿¹Ì壨IgG£©µÄ»ù±¾½á¹¹¡¢¸÷²¿Î»¹¦Äܼ°ÕâÈý´ú¿¹ÌåµÄÌØÐÔ¡£ 8`LLHX1|
3. ʲôÊÇ×ÔÉíÃâÒß²¡£¿ÊÔÊöÆä·¢²¡»úÖÆ¡£ BUy}Rn
4. ÃâÒßϵͳɱÉË°Ðϸ°ûµÄ·½Ê½¼°ÏàӦϸ°ûºÍ·Ö×ÓÓÐÄÄЩ£¿ÊÔÊöTc½éµ¼µÄϸ°ûÃâÒßÓ¦´ð¡£ XGrxzO|{
5. »úÌåµÄÃâÒßϵͳΪʲô¿ÉÒÔʶ±ð×Ô¼ººÍÒ켺£¿ÆäÖ÷Òª»úÖÆÊÇʲô£¿ ?'$.
-z:
px(1Ppb9
s)7`r6w
7zkm
$lG--s
|sZ9/G7
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ J`D<
qI%9MI;BV
WZO
0u
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧרҵ¿Î¿¼ÊÔÊÔÌâ m5Laq'~0_
¿¼ÊÔ¿ÆÄ¿£ºÒ½Ñ§ÃâÒßѧ Yr(f iI
Ò»¡¢ ½âÊÍÏÂÁÐÃû´Ê +VI0 oo {Z
1. C3b½éµ¼µÄµ÷Àí×÷Óà 2.Tϸ°û¼¤»îµÄµÚ¶þÐźÅ3.Th1ϸ°û 4.HLAµÄ¶à̬ÐÔ M+&eh*:z:
5.C1ÒÖÖÆÎï 6.TCR¦Ã¦ÄTϸ°û7.³Ù·¢Ðͳ¬Ãô·´Ó¦ 8.Ç÷»¯ÐÔϸ°ûÒò×Ó9.ÃâÒßÇòµ°°×µÄÀà±ðת»¯ 10.ÔìѪ¸Éϸ°û 1nM?>j%k
11.»î»¯ÓÕµ¼µÄϸ°ûËÀÍö V9 t:JY
¶þ¡¢ Çë»Ø´ðÏÂÁÐÎÊ´ð 1ZH8/1gWI
1. ºÎνµ¥¿Ë¡¿¹Ì壬¼òÊöÆäÖƱ¸ÔÀí¡£ vH\nL>r
2. ¼òÊöTϸ°ûÔÚÐØÏÙÄڵķ¢Óý¹ý³Ì¡£ _@3O`
3. ÃâÒßϸ°û±íÃæÖ÷ÒªÓÐÄļ¸Àà±íÃ濹ԺͱíÃæÊÜÌ壬¼òÊö¸÷Àà·Ö×ÓµÄÖ÷Òª¹¦ÄÜ¡££¨HLA¡¢CD¡¢AM¡¢CKR¡¢CR¡¢MitogenR¡¢TCR¡¢BCR¡¢FcR£© C g,w6<7
4. ÊԱȽÏTCR¸´ºÏÌåºÍBCR¸´ºÏÌå½á¹¹Ó빦ÄܵÄÒìͬ¡£ [zt&8g
5. ÊԱȽϳ¬¿¹ÔÓëÆÕͨ¿¹ÔµÄÒìͬ¡£ %;XuA*e
E]Gq!fA&<
#S74C*'8
a+Qj[pS
Qz90 mb
ZFw743G
»ªÖпƼ¼´óѧͬ¼ÃҽѧԺ sU3V
)7"
2001ÄêÕÐÊÕ˶ʿÑо¿ÉúÈëѧµ¥¶À¿¼ÊÔÊÔÌâ "Q!{8 9Y
¿¼ÊÔ¿ÆÄ¿£ºÃâÒßѧ /|^^v DL
/u1zRw
Ò»¡¢ Ãû´Ê½âÊÍ n7<-lQRaxZ
1. ¿¹Ô³ÊµÝ 2. µ÷Àí×÷Óà 3. ³Áµí·´Ó¦ 4. ×ÔÉíÃâÒß UVRV7^eTe
5. GVHR 6. ÔìѪ¸Éϸ°û 7. ¿Ë¡ѡÔñѧ˵ 8. Ir»ùÒò IaqN@IlWb
9. ³¬Ãô·´Ó¦ 10. ³¬¿¹Ô Olr
w>YbW
¶þ¡¢ÎÊ´ðÌâ ep1Ajz.l
11. ¼òÊö²¹ÌåµÄÅÔ·¼¤»î;¾¶ Ho
{?m^
12. ¼òÊöT¡¢Bϸ°ûÌØÕ÷µÄ²îÒì xg!\C@
$
13. ¼òÊöT¡¢Bϸ°û¿¹Ô¾ö¶¨´ØµÄ²îÒì 9K_HcLO%y
14. ΪʲôÃâÒßÇòµ°°×¾ßÓп¹ÔÐÔ£¿ÊÔÊöÃâÒßÇòµ°°×µÄ¿¹ÔÐÔ¡£
T[K?A+l
15. ʲôÊÇÖ×Áö¿¹Ô£¿ÊÔÊö»úÌåÕë¶ÔÖ×Áö¿¹Ô²úÉú¿¹Ö×ÁöÃâÒßÓ¦´ðµÄ»úÖÆ¡£ )u:8Pv
}{PtQc6RL!